- Home
- KNSA vs SYNA Comparison
KNSA vs SYNA Comparison
Compare KNSA & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- SYNA
- Stock Information
- Founded
- KNSA 2015
- SYNA 1986
- Country
- KNSA United Kingdom
- SYNA United States
- Employees
- KNSA N/A
- SYNA N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- SYNA Computer peripheral equipment
- Sector
- KNSA Health Care
- SYNA Technology
- Exchange
- KNSA Nasdaq
- SYNA Nasdaq
- Market Cap
- KNSA 2.0B
- SYNA 2.2B
- IPO Year
- KNSA 2018
- SYNA 2002
- Fundamental
- Price
- KNSA $26.03
- SYNA $59.83
- Analyst Decision
- KNSA Strong Buy
- SYNA Buy
- Analyst Count
- KNSA 6
- SYNA 10
- Target Price
- KNSA $38.00
- SYNA $96.67
- AVG Volume (30 Days)
- KNSA 677.6K
- SYNA 431.3K
- Earning Date
- KNSA 04-29-2025
- SYNA 05-08-2025
- Dividend Yield
- KNSA N/A
- SYNA N/A
- EPS Growth
- KNSA N/A
- SYNA N/A
- EPS
- KNSA N/A
- SYNA 4.13
- Revenue
- KNSA $481,166,000.00
- SYNA $1,038,900,000.00
- Revenue This Year
- KNSA $37.21
- SYNA $13.20
- Revenue Next Year
- KNSA $1.53
- SYNA $10.04
- P/E Ratio
- KNSA N/A
- SYNA $14.52
- Revenue Growth
- KNSA 59.45
- SYNA 10.60
- 52 Week Low
- KNSA $17.38
- SYNA $41.80
- 52 Week High
- KNSA $28.56
- SYNA $98.00
- Technical
- Relative Strength Index (RSI)
- KNSA 63.21
- SYNA 58.80
- Support Level
- KNSA $25.97
- SYNA $56.40
- Resistance Level
- KNSA $28.56
- SYNA $59.07
- Average True Range (ATR)
- KNSA 1.24
- SYNA 2.18
- MACD
- KNSA 0.36
- SYNA 1.13
- Stochastic Oscillator
- KNSA 71.70
- SYNA 81.14
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.